Ewing’s sarcoma is cancer that begins in bone or soft tissues. Though it makes up only 1% of all childhood cancers, Ewing’s sarcoma is the second most commonly diagnosed bone cancer in children. Ewing’s sarcoma typically affects children and adolescents between the ages of 10 and 20 years, although younger children can be affected. The cell of origin remains uncertain, so the exact cause of Ewing’s sarcoma is unknown.
Early signs of Ewing’s sarcoma are pain and swelling in the affected area of the body, which is most commonly the pelvis, trunk or thigh. This cancer can metastasize to other areas of the body, most often the lungs, if cancer cells enter the bloodstream. Ewing’s sarcoma is curable in most children and adolescents. Patient specific prognosis depends on the tumor’s origin, size, stage and response to treatment.
Our program provides a full range of treatment, even for children with the most challenging cancers. Our program is the lead site for a statewide study of soft tissue sarcoma, looking for genetic targets in these cancerous tumors and then developing new personalized therapies.
Once the cancer is diagnosed, our team will create an individualized treatment plan that will involve chemotherapy drugs to systemically destroy cancerous cells. Surgery and radiation therapy, if applicable, are other important steps to treat Ewing’s sarcoma. A number of families travel to Children’s Health because of our leading therapies backed by the latest research.
Many children with Ewing’s sarcoma are treated with therapy as part of ongoing clinical trials. Physicians at Children’s Health lead the development of such advanced therapy through trials initiated at UT Southwestern and Children’s Health, those of the Children’s Oncology Group and other groups. This allows patients to receive cutting-edge therapies available at few hospitals in the U.S.
Children’s Health is staffed by expert and experienced oncologists, surgeons and subspecialists. The Pauline Allen Gill Center for Cancer and Blood Disorders is a world-class and nationally recognized leader in pediatric cancer. If your child has been diagnosed with Ewing’s sarcoma or you want an expert second opinion, turn to our team of world class pediatric tumor specialists who are dedicated to finding the solution to even the most complex of children’s cancers.